GABRIELLA MELAHN: Open Payments
NPI 1780357103 · HILLSBOROUGH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,193 in 144 payments from 20 companies in 2025. Trend: 2023 $962 · 2024 $1,050 · 2025 $2,193
Food & beverage: $1,976Education: $217
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $317 |
| Janssen Biotech, Inc. | 12 | $294 |
| Incyte Corporation | 20 | $272 |
| Amgen Inc. | 15 | $241 |
| E.R. Squibb & Sons, L.L.C. | 15 | $176 |
| Novartis Pharmaceuticals Corporation | 7 | $160 |
| Lilly USA, LLC | 15 | $148 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| PFIZER INC. | 5 | $80 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $79 |
Products named: TREMFYA, OPZELURA, SKYRIZI, OTEZLA, Sotyktu, DUPIXENT, EBGLYSS, COSENTYX.
Industry payments across NJ — which companies pay providers there.
